Go to the list of all blogs
Arthur Evans's Avatar
published in Blogs
Jul 28, 2026
Why Is Advanced Micro Devices (AMD) Stock Down -7.87% Today?

Why Is Advanced Micro Devices (AMD) Stock Down -7.87% Today?

Key Takeaways

  • AMD shares tumbled approximately 7.87% on Tuesday, extending a brutal two-day semiconductor selloff that has wiped out billions in market value across the chip sector.
  • The primary catalyst is escalating fears of Chinese competition, headlined by CXMT's blockbuster $487-billion IPO debut in Shanghai and reports that a state-backed Chinese firm has begun mass-producing DUV lithography equipment.
  • A separate report that Chinese AI firm DeepSeek is developing its own inference chip, potentially reducing reliance on AMD and Nvidia hardware, added fresh pressure.
  • Broader concerns over "circular AI financing" — exemplified by Nvidia's reported $250-billion OpenAI data-center financing talks — have soured sentiment toward AI infrastructure stocks.
  • The selloff is compounded by a risk-off posture ahead of the Federal Reserve's policy decision and earnings from Microsoft, Meta, Apple, and Amazon later this week.
  • Traders are closely watching whether AMD can hold key support levels, with the company's own quarterly earnings report expected in early August.

Opening Summary

Shares of AMD (Advanced Micro Devices, Inc.), the Santa Clara-based semiconductor giant known for its CPUs, GPUs, and AI accelerators, plunged roughly 7.87% in Tuesday's trading session to approximately $456.00, building on Monday's 5.17% decline that ended at $494.95. The selloff marks a sharp acceleration of losses for a stock that had been among the market's strongest performers, surging over 130% earlier in 2026. The two-day rout reflects a deepening crisis of confidence across the global semiconductor industry, triggered by a confluence of competitive threats from China, anxiety over how the AI infrastructure buildout is being financed, and a wave of profit-taking ahead of a pivotal week of central bank decisions and Big Tech earnings.

China's CXMT IPO Sends Shockwaves Through Global Chip Markets

The most immediate trigger for Tuesday's semiconductor rout traces back to Shanghai, where Chinese memory chipmaker ChangXin Memory Technologies (CXMT) made its public-market debut with a staggering 466% first-day surge. The IPO briefly valued CXMT at approximately $487 billion, making it China's most valuable listed company — larger than its giant state-owned banks — and instantly establishing the firm as the world's fourth-largest DRAM producer, directly behind Samsung, SK Hynix, and Micron.

While CXMT currently produces standard DDR5 memory rather than the high-bandwidth memory (HBM) that powers advanced AI accelerators, the sheer scale of its market debut rattled investors who had long assumed that China remained years behind in competitive chip manufacturing. The IPO's oversubscription — reportedly more than 200 times for the retail tranche — signaled enormous domestic appetite for semiconductor sovereignty, raising the specter of future oversupply and pricing pressure across the memory market. The shock rippled through Asian exchanges first, with South Korea's Kospi index triggering circuit breakers before closing down 10.8%, and Japanese memory firm Kioxia plunging over 18%. U.S. chip stocks, including AMD, absorbed the blow when trading resumed.

China's DUV Lithography Breakthrough and DeepSeek's Chip Ambitions

Compounding the CXMT shock, separate reports revealed that a Chinese state-backed entity has commenced mass production of immersion deep-ultraviolet (DUV) lithography machines — the critical equipment used to manufacture advanced semiconductors. The development poses a direct long-term threat to Dutch lithography leader ASML and Japanese suppliers Nikon and Tokyo Electron, whose shares also suffered double-digit losses. For AMD, the implication is clear: a more self-sufficient Chinese semiconductor ecosystem could erode demand for imported chips and intensify price competition across multiple product categories.

Adding yet another layer of pressure, Reuters reported early Tuesday that Chinese AI developer DeepSeek is designing its own inference chip — a move that, if successful, could reduce the company's dependence on AMD and NVDA GPUs. While chip development is notoriously complex and expensive, the report reinforced a growing narrative that major AI customers may eventually pursue proprietary silicon, shrinking the addressable market for third-party suppliers.

Circular AI Financing Fears Rattle Investor Confidence

Beyond the China-specific headlines, a deeper unease has taken hold regarding the financial mechanics underpinning the AI boom. Reports that NVDA is in talks to provide approximately $250 billion in financial guarantees for an OpenAI data-center project — and potentially another $350 billion for chip purchases — ignited a debate about "circular AI financing," wherein the same companies selling AI hardware are effectively funding the customers buying it. Credit default swaps for Nvidia, Oracle, Alphabet, Amazon, Meta, and Broadcom all surged to record highs, indicating mounting concern that AI capital expenditure may be inflating a credit bubble. AMD, while not directly involved in these financing arrangements, has been swept up in the sector-wide repricing as investors reappraise the sustainability of AI infrastructure spending.

Market Context and Trading Activity

The selloff in AMD shares has been accompanied by markedly elevated trading volume, with Monday's session alone seeing over 15.5 million shares change hands. The Philadelphia Semiconductor Index (SOX) dropped over 2% on Monday and continued to face pressure Tuesday, confirming that the weakness is sector-wide rather than company-specific. The broader Nasdaq Composite has underperformed the Dow Jones Industrial Average, underscoring a rotation away from high-beta technology and semiconductor names. AMD has now fallen roughly 18% from its late-June record high, breaching several near-term moving averages and approaching oversold territory on the 14-day RSI.

What Comes Next for AMD

The road ahead for AMD is defined by several near-term catalysts. The company is expected to report its second-quarter earnings in early August, with Wall Street laser-focused on data-center segment growth, MI-series GPU demand, and whether the recently announced Anthropic partnership and Helios rack-scale platform are translating into tangible revenue momentum. The Federal Reserve's policy decision on Wednesday and Big Tech earnings from Microsoft, Meta, Apple, and Amazon will set the macro and sector tone. On the bullish side, analysts at Wedbush and Mizuho recently raised their price targets following AMD's Advancing AI event, citing confidence in accelerated data-center revenue growth in the second half of 2026. Conversely, the risk remains that competitive pressures from China and a potential cooling of AI infrastructure investment could challenge the premium valuation that AMD shares command.

Trending AI Robots

In volatile markets like today's semiconductor-led selloff, traders often turn to systematic, data-driven tools to manage risk and identify opportunities. Tickeron operates a dedicated Trending AI Robots page that curates hundreds of AI-powered trading bots covering thousands of tickers, including AMD. Only the strongest-performing bots under current market conditions are featured in this curated selection, with each bot differing by strategy, trading timeframe, performance metrics, and the symbols it trades. For those navigating today's semiconductor turbulence, exploring the Trending AI Robots may offer a disciplined complement to discretionary decision-making.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: AMD

Contributor

Financial writer and active order flow futures trader with a focus on fundamental analysis, macroeconomic factors, and equity research. I make in-depth blogs on stocks and ETFs, bridging the gap between raw market data and real-world trading decisions.


AMD in upward trend: price expected to rise as it breaks its lower Bollinger Band on July 28, 2026

AMD may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In of 35 cases where AMD's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 58 cases where AMD's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where AMD advanced for three days, in of 313 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on July 23, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on AMD as a result. In of 76 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

AMD moved below its 50-day moving average on August 05, 2026 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for AMD crossed bearishly below the 50-day moving average on July 29, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In of 14 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where AMD declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for AMD entered a downward trend on August 05, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 73, placing this stock better than average.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. AMD’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (11.876) is normal, around the industry mean (16.094). P/E Ratio (124.816) is within average values for comparable stocks, (162.735). Projected Growth (PEG Ratio) (1.048) is also within normal values, averaging (1.904). AMD has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.015). P/S Ratio (19.531) is also within normal values, averaging (47.773).

Notable companies

The most notable companies in this group are NVIDIA Corp (NASDAQ:NVDA), Broadcom Inc. (NASDAQ:AVGO), Taiwan Semiconductor Manufacturing Company Ltd (NYSE:TSM), Micron Technology (NASDAQ:MU), Advanced Micro Devices (NASDAQ:AMD), Intel Corp (NASDAQ:INTC), Texas Instruments (NASDAQ:TXN), Marvell Technology (NASDAQ:MRVL), Analog Devices (NASDAQ:ADI), QUALCOMM (NASDAQ:QCOM).

Industry description

The semiconductor industry manufacturers all chip-related products, including research and development. These chips are used in innumerable electronic devices, including computers, cell phones, smartphones, and GPSs. Intel Corporation, NVIDIA Corp., and Broadcomm are some of the prominent players in this industry. Semiconductor companies usually tend to do well during periods of healthy economic growth, thereby inducing further research and development in the industry – which in turn augurs well for productivity and growth in the economy. In the near future, demand for semiconductor products (and possibly innovation within the segment) should only expand further, with the proliferation of 5G, autonomous vehicles, IoT, and various AI-driven electronics set to herald a new, advanced chapter in the technology-driven world as we know it. With burgeoning prospects comes great competition. In 2015, SIA estimated that U.S. semiconductor industry ranks as the second most competitive U.S. industry out of 2882 U.S. industries designated manufacturers by the U.S. Census Bureau.

Market Cap

The average market capitalization across the Semiconductors Industry is 187.57B. The market cap for tickers in the group ranges from 13.43K to 5.31T. NVDA holds the highest valuation in this group at 5.31T. The lowest valued company is CYBL at 13.43K.

High and low price notable news

The average weekly price growth across all stocks in the Semiconductors Industry was 7%. For the same Industry, the average monthly price growth was -4%, and the average quarterly price growth was 43%. SITM experienced the highest price growth at 30%, while ON experienced the biggest fall at -6%.

Volume

The average weekly volume growth across all stocks in the Semiconductors Industry was -34%. For the same stocks of the Industry, the average monthly volume growth was -31% and the average quarterly volume growth was -62%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 60
P/E Growth Rating: 53
Price Growth Rating: 48
SMR Rating: 75
Profit Risk Rating: 73
Seasonality Score: -27 (-100 ... +100)
View a ticker or compare two or three
AMD
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

a manufacturer of integrated circuits for semiconductors

Industry Semiconductors

Profile
Details
Industry
Semiconductors
Address
2485 Augustine Drive
Phone
+1 408 749-4000
Employees
31000
Web
https://www.amd.com
Interact to see
Advertisement
Novartis (NVS) reports Q4/FY 2025 earnings on February 4, 2026, with consensus calling for ~$1.99 EPS on ~$13.7 billion in revenue. Sanofi (SNY) delivered strong FY 2025 results on January 29, reporting €43.6 billion in sales (+9.9% CER) and 15% business EPS growth.
Novo Nordisk (NVO) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $11.96 billion in revenue and $0.89 EPS, reflecting a moderation in GLP-1 growth. Eli Lilly (LLY) is expected to report around the same time, with projections of $17.87 billion in revenue and $6.99 EPS, driven by continued volume gains from Mounjaro and Zepbound.
MUFG is expected to report Q3 FY2026 EPS of about $0.30, broadly in line with its recent pattern of earnings beats.
Banco Santander (SAN) reports Q4 2025 earnings on February 4, 2026, following record nine-month attributable profit of €10.3 billion, up 11% year over year.
Uber (UBER) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $0.78 EPS and $14.32 billion in revenue, up about 20% year over year.
Qualcomm’s Q1 FY2026 report, covering the period ended December 28, 2025, arrives amid a pivotal shift in the semiconductor landscape. While handset growth moderates, the company is expanding in automotive, IoT, and AI-enabled devices.
UBS Group AG reports Q4 2025 earnings on February 4, 2026, with consensus EPS ranging $0.25–$0.67 and revenue around $11.62 billion, down YoY. HSBC Holdings plc reports Q4 earnings on February 25, 2026, with consensus EPS ~$1.57; Q3 showed resilient net interest income despite $1.4B in legal provisions.
Boston Scientific’s Q4 caps a transformative year, driven by ~15.5% organic growth from WATCHMAN, FARAPULSE electrophysiology, and MedSurg expansions. As a leader in minimally invasive devices, BSX’s results set the benchmark against Medtronic and Stryker—diversified medtech giants navigating tariffs, procedural rebounds, and innovation.
Arm, the leading provider of energy-efficient processor designs powering over 99% of smartphones and expanding into AI data centers, faces high scrutiny in Q3 FY2026 (ending Dec 31, 2025). After a strong Q2 with record royalty and licensing revenue, investors are focused on whether AI demand will continue to drive robust growth.
CME Group (CME): Q4 2025 earnings due February 4, 2026; consensus expects adjusted EPS $2.75 and revenue ~$1.6B. S&P Global (SPGI): Q4 2025 earnings due February 10, 2026; Q3 posted EPS $4.73 and 9% revenue growth, driven by Ratings, Indices, and Market Intelligence.
Datadog (DDOG) has come under pressure in recent sessions as volatility across the software sector weighs on sentiment ahead of earnings. Trading in the $108–120 range following a pullback from highs near $200, the stock reflects a disconnect between near-term market caution and resilient underlying fundamentals.
Starbucks shares have shown renewed strength in recent trading, rebounding from earlier lows within a 52-week range of $75.50 to $117.46. The recovery reflects improving comparable sales trends and a return to transaction growth, suggesting early progress from operational initiatives aimed at reconnecting with customers.
DoorDash holds a Strong Buy consensus from 33 analysts, with an average 12-month price target of $280.82, implying more than 40% upside from recent trading levels.
Amazon’s Q4 report capped a strong year marked by accelerating cloud growth, steady retail execution, and expanding advertising profitability. The results reinforced Amazon’s positioning as a core beneficiary of enterprise AI demand, particularly through AWS, while highlighting improving operating leverage across the broader business.
ConocoPhillips reported Q4 2025 adjusted EPS of $1.02, below consensus of $1.08, driven by weaker realized commodity prices.
ICE reported Q4 2025 net revenues of $2.5 billion, up 8% year-over-year, capping 20 consecutive years of record annual revenues at $9.9 billion.
Eli Lilly’s Q4 results highlight explosive growth from GLP-1 therapies, cementing leadership in obesity and diabetes. The company’s strong revenue beat and robust 2026 guidance illustrate high-growth pharma dynamics. Johnson & Johnson, in contrast, exemplifies a diversified healthcare strategy, combining pharmaceuticals, MedTech, and consumer health for steady expansion.
Eli Lilly (LLY), AbbVie (ABBV), and Merck (MRK) all reported strong Q4 2025 earnings, but the market reacted differently to each, reflecting variations in growth profiles, product concentration, and sector dynamics. AbbVie delivered Q4 revenue of $16.62 billion, up 10% year-over-year, with full-year revenue reaching $61.2 billion, an 8.6% increase. Adjusted EPS came in at $2.71, surpassing consensus, though shares dipped following the report amid ongoing Humira concerns
Novo Nordisk (NVO) reported Q4 2025 EPS of $1.02, surpassing estimates of $0.92, with revenue of $12.53B vs $11.99B expected. Full-year 2025 sales rose 10% at constant exchange rates (CER) to DKK 309B, but 2026 guidance anticipates a 5–13% decline at CER due to pricing pressures. Novartis (NVS) posted Q4 core EPS of $2.03, beating $1.99 estimates; net sales of $13.34B slightly missed consensus. FY sales grew 8%, with core EPS up 17% to $8.98.
MUFG (Mitsubishi UFJ Financial Group) posted Q3 FY2026 profits of ¥1.81 trillion, up 3.7% YoY, on track for its full-year target of ¥2.1 trillion. HSBC is set to report Q4 FY2025 earnings on Feb 25, 2026, with consensus EPS around $1.60; recent quarters showed resilient net interest income (NII) supported by Asia wealth growth.